Novel therapeutic approaches targeting genetic mutations in BRAF, MEK, RAS family of proteins, c-KIT, c-Met, VEGFR, and PI3K have been illustrated and implicated in the reduction of cell proliferation and cell survival in melanoma as well other forms of cancer. Here, KIT is linked to melanoma.